QL ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
QL04 IMMUNOSUPPRESSANTS
QL04A IMMUNOSUPPRESSANTS
QL04AG Monoclonal antibodies
QL04AG01 muromonab-CD3
QL04AG02 efalizumab
QL04AG03 natalizumab
QL04AG04 belimumab
QL04AG05 vedolizumab
QL04AG06 alemtuzumab
QL04AG07 begelomab
QL04AG08 ocrelizumab
QL04AG09 emapalumab
QL04AG10 inebilizumab
QL04AG11 anifrolumab
QL04AG12 ofatumumab
QL04AG13 teprotumumab
QL04AG14 ublituximab
QL04AG15 divozilimab
QL04AG16 rozanolixizumab
QL04AG90 cirevetmab
Last updated: 2024-01-17